UBE2D1 and hepatocellular carcinoma: UBE2D1, previously shown to be upregulated by VPA in SH-SY5Y neuronal cells and associated with hepatocellular carcinoma progression [46], was similarly elevated in VPA monotherapy and reversed with FA, suggesting FA may counteract such adverse proliferative effects.